knowledge transfer
transfer new skills
new high-throughput
new approaches
formation of specific protein complexes
EU ESRs
discovery of new lead molecules
mobility of non-EU researchers
EU-based research
small molecules
Establishment of EPIC
inward transfer of essential knowledge
development of new skill-sets
Fluorescence resonance transfer
apoptosome formation
research activity
complex formation
potential of researchers
cells
absence of robust high-throughput assays
high-content screening assays
early stage researchers
academia-industry partnerships
Cell-death
life-and-death decisions
key events
measure necrosome
Inappropriate decisions
RISE award
proposed network
development of career opportunities
plethora of disease conditions
training of experienced
degenerative diseases
novel reagents
expertise
cancer
world
communal effort
national funding agencies
Europe
applications
processes
role
split-luciferase technologies
pharma
H2020 work programme
demonstrable utility
inability
important therapeutic targets
biotech
problems
intellectual property
therapeutics